Cellular reprogramming and fate conversion

Masaki Ieda

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cellular reprogramming and fate conversion have long been recognized in somatic nuclear transfer and cell fusion experiments. The potency of specific transcription factors as cell fate determinants was first demonstrated by the discovery of MyoD, a master gene for skeletal muscle differentiation, and by the subsequent identification of several genes as lineage-converting factors within the blood cell lineage. These pioneer works led to the landmark study by Dr. Yamanaka and colleagues in 2006 that is reprogramming of somatic cells into a pluripotent state by transduction of the four stem cell-specific transcription factors, Oct4, Sox2, Klf4, and c-Myc. This study fundamentally altered the approach to regenerative medicine and also inspired a broad strategy to generate desired cell types by introducing combinations of lineage-specific transcription factors. In fact, it has been demonstrated that a diverse range of cell types, such as pancreatic β cells, neurons, cardiomyocytes, and hepatocytes, could be directly induced from heterologous cells by combinations of lineage-specific reprogramming factors. This chapter reviews the pioneer and recent works of cellular reprogramming and fate conversion, and also discusses the future perspective and challenges of using this technology in regenerative medicine.

Original languageEnglish
Title of host publicationAdvances in Stem Cell Research
PublisherHumana Press Inc.
Pages211-225
Number of pages15
ISBN (Electronic)9781617799402
ISBN (Print)9781617799396
DOIs
Publication statusPublished - 2012 Jan 1

Fingerprint

Transcription Factors
Regenerative Medicine
Cell Lineage
Genes
Nuclear Fusion
Stem cells
Neurons
Muscle
Cell Fusion
Blood
Fusion reactions
Cells
Cardiac Myocytes
Hepatocytes
Blood Cells
Skeletal Muscle
Stem Cells
Technology
Cellular Reprogramming
Experiments

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Ieda, M. (2012). Cellular reprogramming and fate conversion. In Advances in Stem Cell Research (pp. 211-225). Humana Press Inc.. https://doi.org/10.1007/978-1-61779-940-2_12

Cellular reprogramming and fate conversion. / Ieda, Masaki.

Advances in Stem Cell Research. Humana Press Inc., 2012. p. 211-225.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ieda, M 2012, Cellular reprogramming and fate conversion. in Advances in Stem Cell Research. Humana Press Inc., pp. 211-225. https://doi.org/10.1007/978-1-61779-940-2_12
Ieda M. Cellular reprogramming and fate conversion. In Advances in Stem Cell Research. Humana Press Inc. 2012. p. 211-225 https://doi.org/10.1007/978-1-61779-940-2_12
Ieda, Masaki. / Cellular reprogramming and fate conversion. Advances in Stem Cell Research. Humana Press Inc., 2012. pp. 211-225
@inbook{70d58b1fa8284678b6bae2ba77ccd742,
title = "Cellular reprogramming and fate conversion",
abstract = "Cellular reprogramming and fate conversion have long been recognized in somatic nuclear transfer and cell fusion experiments. The potency of specific transcription factors as cell fate determinants was first demonstrated by the discovery of MyoD, a master gene for skeletal muscle differentiation, and by the subsequent identification of several genes as lineage-converting factors within the blood cell lineage. These pioneer works led to the landmark study by Dr. Yamanaka and colleagues in 2006 that is reprogramming of somatic cells into a pluripotent state by transduction of the four stem cell-specific transcription factors, Oct4, Sox2, Klf4, and c-Myc. This study fundamentally altered the approach to regenerative medicine and also inspired a broad strategy to generate desired cell types by introducing combinations of lineage-specific transcription factors. In fact, it has been demonstrated that a diverse range of cell types, such as pancreatic β cells, neurons, cardiomyocytes, and hepatocytes, could be directly induced from heterologous cells by combinations of lineage-specific reprogramming factors. This chapter reviews the pioneer and recent works of cellular reprogramming and fate conversion, and also discusses the future perspective and challenges of using this technology in regenerative medicine.",
author = "Masaki Ieda",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/978-1-61779-940-2_12",
language = "English",
isbn = "9781617799396",
pages = "211--225",
booktitle = "Advances in Stem Cell Research",
publisher = "Humana Press Inc.",

}

TY - CHAP

T1 - Cellular reprogramming and fate conversion

AU - Ieda, Masaki

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Cellular reprogramming and fate conversion have long been recognized in somatic nuclear transfer and cell fusion experiments. The potency of specific transcription factors as cell fate determinants was first demonstrated by the discovery of MyoD, a master gene for skeletal muscle differentiation, and by the subsequent identification of several genes as lineage-converting factors within the blood cell lineage. These pioneer works led to the landmark study by Dr. Yamanaka and colleagues in 2006 that is reprogramming of somatic cells into a pluripotent state by transduction of the four stem cell-specific transcription factors, Oct4, Sox2, Klf4, and c-Myc. This study fundamentally altered the approach to regenerative medicine and also inspired a broad strategy to generate desired cell types by introducing combinations of lineage-specific transcription factors. In fact, it has been demonstrated that a diverse range of cell types, such as pancreatic β cells, neurons, cardiomyocytes, and hepatocytes, could be directly induced from heterologous cells by combinations of lineage-specific reprogramming factors. This chapter reviews the pioneer and recent works of cellular reprogramming and fate conversion, and also discusses the future perspective and challenges of using this technology in regenerative medicine.

AB - Cellular reprogramming and fate conversion have long been recognized in somatic nuclear transfer and cell fusion experiments. The potency of specific transcription factors as cell fate determinants was first demonstrated by the discovery of MyoD, a master gene for skeletal muscle differentiation, and by the subsequent identification of several genes as lineage-converting factors within the blood cell lineage. These pioneer works led to the landmark study by Dr. Yamanaka and colleagues in 2006 that is reprogramming of somatic cells into a pluripotent state by transduction of the four stem cell-specific transcription factors, Oct4, Sox2, Klf4, and c-Myc. This study fundamentally altered the approach to regenerative medicine and also inspired a broad strategy to generate desired cell types by introducing combinations of lineage-specific transcription factors. In fact, it has been demonstrated that a diverse range of cell types, such as pancreatic β cells, neurons, cardiomyocytes, and hepatocytes, could be directly induced from heterologous cells by combinations of lineage-specific reprogramming factors. This chapter reviews the pioneer and recent works of cellular reprogramming and fate conversion, and also discusses the future perspective and challenges of using this technology in regenerative medicine.

UR - http://www.scopus.com/inward/record.url?scp=85026440552&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026440552&partnerID=8YFLogxK

U2 - 10.1007/978-1-61779-940-2_12

DO - 10.1007/978-1-61779-940-2_12

M3 - Chapter

SN - 9781617799396

SP - 211

EP - 225

BT - Advances in Stem Cell Research

PB - Humana Press Inc.

ER -